DR TIM SPAREY

Business Development

Dr. Tim Sparey is a serial entrepreneur with over 24 years of experience in large pharma and biotech companies. He is a medicinal chemist by background and spent 11 years in CNS R&D with Merck & Co working on novel targets in Alzheimer’s, Parkinson’s, anxiety, depression and anaesthetics. He then spent three years working in Merck’s Global BD&L team sourcing and evaluating technologies in all disease areas. Since leaving Merck & Co in 2008, he has held board level, C-suite CEO and CBO positions in four biotech companies. In these roles he built, developed and transacted in multiple disease areas including CNS, inflammation, ophthalmology and cancer in deals totalling over $1bn in value. His biotech experience is in private and public companies including Proximagen (CBO), Q Chip (CEO) and Midatech (CBO). Tim is currently the CEO and co-founder of Novintum Bio. In partnership with the Executive Team, he built the Management Team and Scientific Advisory Board, designed the research strategy, set the corporate culture and drives development activities. In addition, he advises numerous groups including Deep Science Ventures and consultancy clients on strategy, corporate development, fundraising and business development.

 
  • Twitter

©2020 DRUG DISCOVERY AND DEVELOPMENT CONSULTANTS LTD. TRADING AS 3D CONSULTANTS. REGISTERED IN ENGLAND AND WALES, COMPANY NUMBER 11438683